INTAI Business Summary

INTAI Technology Corporation (4163.TWO) is a premier Taiwanese precision manufacturer specializing in high-complexity medical devices, which currently account for over 65% of its total revenue. The company operates a diversified business model encompassing Original Equipment Manufacturing (OEM), Original Design Manufacturing (ODM), and Own Brand Manufacturing (OBM) for its proprietary orthopedic and dental implant lines. Its primary revenue segments are divided into Medical Devices (minimally invasive surgery tools, laparotomy instruments, and spinal implants), Precision Fasteners (serving automotive and industrial sectors), and RF Microwave Switches (targeting aerospace and telecommunications). INTAI maintains a critical role in the global healthcare supply chain as a strategic partner for multinational giants such as Johnson & Johnson, Boston Scientific, and AtriCure. Within the competitive landscape, INTAI competes directly with specialized medical contract manufacturers like United Orthopedic (4116.TW) and global CDMO leaders such as Integer Holdings (ITGR) and Viant Medical, distinguishing itself through vertically integrated capabilities in Nitinol processing and femtosecond laser-cutting technology. The company was founded in 1988 by Chairman Paul Lin (Lin Chih-Teng), a self-taught mechanical expert who transitioned the firm from a small-scale fastener shop into a high-tech biomedical powerhouse. The current leadership is spearheaded by CEO and General Manager Jun-Nan Lin (Lin Chun-Nan), who has overseen the company’s expansion into the Taichung Precision Machinery Technological Park and the recent commissioning of the HouLi facility in 2023. The executive team includes Vice President of Medical Devices Donald Wang, who leads the firm's R&D efforts in robotic-assisted surgery components. Notable strategic backing is provided by Catcher Technology (2474.TW), a major shareholder that reinforces INTAI's manufacturing scale. The board is characterized by a mix of founding family members and independent directors with deep pedigrees in electrical engineering and global asset management, ensuring a balance between technical innovation and disciplined capital allocation.